RhoVac AB announced on July 15 2022, that the company's CEO, Anders Månsson, has announced his wish to leave his position with the company no later than after the 3-month stipulated notice period. Pending a final decision regarding the company's future, RhoVac's CEO, Anders Månsson, has decided to give notice of termination of his employment with the company, and he will leave RhoVac no later than September 30.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.53 SEK | +51.43% | -.--% | -6.03% |
Mar. 28 | Chosa Oncology Names CFO, Chief Commercial Officer | MT |
Mar. 28 | CHOSA Oncology AB Announces Chief Financial Officer Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-6.03% | 3.14M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- CHOSA Stock
- News Chosa Oncology AB
- Rhovac AB Announces Resignation of Anders Månsson as CEO